|
Volumn 25, Issue 3, 1998, Pages 381-396
|
Biological therapy of ovarian cancer: Current directions
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
COLONY STIMULATING FACTOR 1;
CYTOKINE;
CYTOTOXIC AGENT;
EPIDERMAL GROWTH FACTOR;
GAMMA INTERFERON;
GROWTH FACTOR RECEPTOR;
IMMUNOTOXIN;
INTERFERON;
INTERLEUKIN 2;
IODINE 131;
MONOCLONAL ANTIBODY;
ONCOPROTEIN;
PSEUDOMONAS EXOTOXIN;
RADIOISOTOPE;
RICIN A;
T LYMPHOCYTE ANTIGEN;
TRANSFERRIN RECEPTOR;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR NECROSIS FACTOR;
UVOMORULIN;
VASCULOTROPIN;
YTTRIUM 90;
ADOPTIVE IMMUNOTHERAPY;
ANIMAL CELL;
BONE MARROW TOXICITY;
CANCER INVASION;
CANCER RESISTANCE;
CAPILLARY LEAK SYNDROME;
CHO CELL;
CLINICAL ARTICLE;
CYTOTOXICITY;
DRUG MECHANISM;
FEMALE;
HUMAN;
HUMAN CELL;
IMMUNOMODULATION;
INTRAPERITONEAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LYMPHOKINE ACTIVATED KILLER CELL;
NATURAL KILLER CELL;
NONHUMAN;
ONCOGENE NEU;
OVARY CARCINOMA;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
T LYMPHOCYTE SUBPOPULATION;
ANTIBODIES, MONOCLONAL;
BIOLOGICAL RESPONSE MODIFIERS;
CANCER VACCINES;
CLINICAL TRIALS;
FEMALE;
HUMANS;
IMMUNOCONJUGATES;
IMMUNOTHERAPY;
IMMUNOTOXINS;
MACROPHAGE COLONY-STIMULATING FACTOR;
NEOPLASM INVASIVENESS;
NEOVASCULARIZATION, PATHOLOGIC;
OVARIAN NEOPLASMS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RECEPTOR, ERBB-2;
RECEPTORS, CYTOKINE;
|
EID: 0031799615
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (57)
|
References (155)
|